AVR 1.73% $17.05 anteris technologies ltd

News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-567

  1. 1,533 Posts.
    lightbulb Created with Sketch. 300
    Replying to yourself is the first sign of dementia HA HA. Have a great Easter to and don't worry about AHZ to much I have this feeling it's all going to work out fine in the end . If the infusion sale goes ahead I can see the SP bouncing back over that 8 c mark which should create another top up to the bank balance . Investor confidence sill seems reasonably strong and the faith in AHZ great products is even stronger , All that is needed is a good announcement or two and hopefully the SP can bounce up closer to where it should be . At that point even if we need another CR the dilution won't be anywhere near what it would be at around 4c . It's a shame the management weren't more thrifty and the CE approval for CardioCel took so long because if all had gone to plan AHZ would now have a SP of over 60 c I feel
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$17.05
Change
-0.300(1.73%)
Mkt cap ! $327.7M
Open High Low Value Volume
$17.00 $17.44 $16.95 $184.6K 10.84K

Buyers (Bids)

No. Vol. Price($)
1 191 $17.15
 

Sellers (Offers)

Price($) Vol. No.
$17.50 500 1
View Market Depth
Last trade - 15.59pm 19/07/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.